We would like to inform you that we are obliged to use "cookies" for the proper functioning of this website. These "cookies" can therefore be stored on your device (PC, tablet, smartphone, etc.). By continuing to browse this website, you agree to the use of these "cookies". This use allows us to adapt the content of our website as precisely as possible and immediately ensures a better and easier browsing experience on our site. More information about this can be found in the Privacy Statement section . PP-MG-BE-0058 Cookie settings Accept all cookies Investors jobs Contact us Globe Lilly Business Science Medicines Responsibility News French (Belgium) Reveal available languages Lilly combines care and discovery to develop medicines that can improve the quality of life for people around the world. Lilly in Belgium More information about our work Research and Scientific Discovery Discover our research Current medicines Knowing more diversity Contact us Suppliers Copyright © 2021 Eli Lilly and Company . All rights reserved. PP-MG-BE-0062 Legal notices Privacy declaration Accessibility statement Route planning Cookie settings Lilly

Skip to main navigation Email Alerts News Lilly.com .st0{fill-rule:evenodd;clip-rule:evenodd;fill:#D52B1E;} .st1{fill:#212121;} Stock Info Webcasts & Presentations Financials Individual Investors Resources Search Investors Latest News November 18, 2021 Emgality® Versus Nurtec® ODT Head-to-Head Migraine Preventive Treatment Study Now Enrolling Patients November 17, 2021 Lilly to Participate in Fourth Annual Evercore ISI HealthCONx Conference November 11, 2021 US FDA accepts supplemental New Drug Application and grants Priority Review for Jardiance® for adults with heart failure independent of left ventricular ejection fraction View All Upcoming Events November 18, 2021 at 10:30 AM EST Wolfe Research Virtual Healthcare Conference November 30, 2021 at 12:10 PM EST 4th Annual Evercore ISI HealthCONx Conference December 15, 2021 at 9:00 AM EST Investment Community Meeting February 3, 2022 at 9:00 AM EST Q4 2021 Earnings Call April 28, 2022 at 9:00 AM EDT Q1 2022 Earnings Call August 4, 2022 at 9:00 AM EDT Q2 2022 Earnings Call View All Clinical Development Pipeline Learn More Quarterly Results View Results 2020 Integrated Summary Report View This Report Key Ratios Key Financial Ratios ESG Learn More Investor Email Alerts Sign up to receive email alerts for various types of investor content. Diversity Contact Suppliers Login To speak to customer support: Call (800) 545-5979 Copyright © 2021 Eli Lilly and Company. All rights reserved. Terms of Use Privacy Statement Accessibility Statement Sitemap